NanoXplore Inc. to Announce Third Quarter Results Conference Call on Tuesday May 17, 2022, and the Nomination of its Director of Investor Relations

NanoXplore Inc. (TSX: GRA and OTCQX: NNXPF) ("NanoXplore") is pleased to hold a conference call to discuss the results of its third quarter ended March 31, 2022, on Tuesday, May 17, 2022, at 8:30 a.m. Eastern Time. The financial results will be released on Monday, May 16, 2022, after the market close.

Details of the Q3 Conference Call

When : May 17, 2022, at 8:30 a.m. Eastern Time

Dial-in number : 1-866-696-5894 (toll free Canada and US) or 416-340-2217 (Toronto area)

Participant code: 4177433#.

Please call 10 minutes prior to the start of the conference call.

There will be a rebroadcast of the call available by dialing 1-800-408-3053 (toll free Canada and US) or 905-694-9451 and enter the participant code 1955519#. The rebroadcast will be available until May 23, 2022.

Nomination of Martin Gagné, Director of Investor Relations

In addition, NanoXplore announced the appointment of Martin Gagné to a newly created position of Director of Investor Relations, effective May 2, 2022. In his role, Martin will oversee all aspects of investor relations activities and will report directly to the CEO and founder Soroush Nazarpour. As Director of Investor Relations, he will be responsible for the development, implementation, and management of a strategic plan for investor relations that will maximize NanoXplore's visibility in the financial community.

Martin brings more than 15 years of experience in the investment industry and holds a CPA and CFA designations. Prior to joining NanoXplore, Martin worked as a senior analyst and Portfolio Manager for asset management firms covering multiple industries in the Canadian and US Equity markets.

About NanoXplore Inc.

NanoXplore is a graphene company, a manufacturer and supplier of high-volume graphene powder for use in transportation and industrial markets. The Company provides standard and custom graphene-enhanced plastic and composite products to various customers in transportation, packaging, electronics, and other industrial sectors. NanoXplore is headquartered in Montreal.

For further information:

Investors and media

Martin Gagné
Director of Investor Relations
martin.gagne@nanoxplore.ca
Tel: 1 438 476 1927


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

GRA:CA,NNXPF
The Conversation (0)
Longeveron® Announces Contract Development and Manufacturing Business and First Contract

Longeveron® Announces Contract Development and Manufacturing Business and First Contract

Contract manufacturing services as a new business line has the potential to generate approximately $4-5 million in annual revenues First manufacturing services contract signed with Secretome Therapeutics Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company... Keep Reading...
Sona's 'THT' Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study

Sona's 'THT' Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study

Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce an innovative research initiative to be undertaken with The Giacomantonio Immuno-Oncology Research Group (the "Research Group"). This study aims to evaluate the efficacy of Sona's Targeted... Keep Reading...
Why Invest in Nanotech Stocks?

Why Invest in Nanotech Stocks?

The nanotechnology market is experiencing a promising stage of growth, making it an attractive space for investors.From nanotech-based solar panels that increase energy efficiency to pharmaceutical products that make use of nanotech in drug-delivery systems, nanotechnology has far-reaching... Keep Reading...

SILO Pharma Inc

SILO Pharma Inc is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research. Keep Reading...
Satellos Bioscience Inc.

Satellos Bioscience Inc.

Satellos Bioscience Inc is a regenerative medicine company dedicated to developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. Its lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this... Keep Reading...
Vaxcyte Inc.

Vaxcyte Inc.

Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. Keep Reading...

Interactive Chart

Latest Press Releases

Related News